+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A new technique for the rapid dissolution of retained ductal gallstones with monooctanoin in t tube patients

A new technique for the rapid dissolution of retained ductal gallstones with monooctanoin in t tube patients

American Surgeon 58(2): 141-145

Retained gallstones in the biliary ducts have been therapeutically managed with monoctanion (Moctanin; Ethitek Pharmaceuticals Company, Skokie, IL) since Food and Drug administration approval in 1985. The clinical usefulness of monoctanion therapy has previously been regarded by some investigators as limited because of the length of time required to achieve complete dissolution (2 to 10 days) and less than optimal results (50% to 86% efficacy). Here, the authors describe a safe technique for the rapid dissolution of retained stones that they have used successfully in four patients. This technique eliminates the need for pressure monitoring in the T-tube patient and is suitable for short-stay hospitalization. Representative case histories are presented.

(PDF emailed within 1 workday: $29.90)

Accession: 006955166

Download citation: RISBibTeXText

PMID: 1550307

Related references

Monooctanoin dissolution of gallstones via a cholecystostomy tube. Radiology 153(2): 547, 1984

Monooctanoin dissolution of retained biliary stones in high risk patients. American Journal of Gastroenterology 78(11): 756-760, 1983

Systemic side effects from the intrabiliary infusion of monooctanoin for the dissolution of gallstones. Journal of Clinical Gastroenterology 4(2): 133-135, 1982

Evaluation of garlic oil as a contact dissolution agent for gallstones: comparison with monooctanoin. Tropical Gastroenterology 21(4): 177-179, 2001

In vitro dissolution of cholesterol gallstones with sodium cholate, heparin and monooctanoin. Revista Medica de Chile 109(7): 601-605, 1981

In vitro dissolution of gallstones: comparison of monooctanoin, sodium dehydrocholate, heparin, and saline. Ajr. American Journal of Roentgenology 138(2): 271-273, 1982

Dissolution of model gallstones in bile acid solutions I: implications for T-tube infusion treatment of retained common duct stones with the cholate system. Journal of Pharmaceutical Sciences 64(12): 2029-2030, 1975

Monooctanoin moctanin a new agent for the dissolution of retained cholesterol bile duct stones. Drugs of Today 22(9): 443-448, 1986

Dissolution of retained duct stones by perfusion with monooctanoin via a Teflon catheter introduced endoscopically. Gastrointestinal Endoscopy 27(2): 63-65, 1981

Dissolution of retained common bile duct stones using monooctanoin. A case report documented with cholangiography. South Dakota Journal of Medicine 35(3): 7-10, 1982

Monooctanoin, a dissolution agent for retained cholesterol bile duct stones: physical properties and clinical application. Gastroenterology 78(5 Pt 1): 1016-1022, 1980

Dissolution of cholesterol and cholesterol calcium gallstones with mtbe and monooctanoin. Radiology 174(3 PART 2): 1079, 1990

Dissolution of cholesterol gallstones in vitro. Gallstone matrix content and diameter, not cholesterol content, predict gallstone dissolution in monooctanoin. Gastroenterology 93(1): 98-105, 1987

Rapid dissolution of retained common bile duct stones by methyl tert-butyl ether. Technique and preliminary results. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 90(4): 715-717, 1986

The treatment of retained biliary stones with monooctanoin: report of 16 patients. American Journal of Gastroenterology 79(9): 710-714, 1984